Emyria (ASX:EMD) extended its multi-year agreement with Medibank (ASX:MPL) to fund treatment for screened and eligible customers to access the firm's treatment-resistant depression program and post-traumatic stress disorder program at Avive Health's Brisbane clinic, according to a Wednesday Australian bourse filing.
Shares of the company fell 2% in recent Wednesday trade.